Cargando…
O5.1. CLOZAPINE AND LONG-TERM MORTALITY RISK IN PATIENTS WITH SCHIZOPHRENIA: PRELIMINARY RESULTS FROM A META-ANALYSIS
BACKGROUND: Patients with schizophrenia have a high mortality risk. The role of clozapine in the long-term mortality risk is insufficiently known. The objectives of the current study were to determine in i) all-cause long-term mortality rates and ii) specific-cause mortality rates and ratios in pati...
Autores principales: | Vermeulen, Jentien, van Rooijen, Geeske, van de Kerkhof, Marita, Sutterland, Arjen, Correll, Christoph, de Haan, Lieuwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887711/ http://dx.doi.org/10.1093/schbul/sby015.215 |
Ejemplares similares
-
T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Bogers, Jan, et al.
Publicado: (2020) -
Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
por: Çakici, Nuray, et al.
Publicado: (2021) -
Meta-analysis of cognitive functioning in patients with psychotic disorders and obsessive–compulsive symptoms
por: Dijkstra, Lotte, et al.
Publicado: (2020) -
Influence of nursing staff attitudes and characteristics on the use of coercive measures in acute mental health services—A systematic review
por: Doedens, Paul, et al.
Publicado: (2020) -
Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
por: Mier, Daniela, et al.
Publicado: (2018)